Products
Online Inquiry

Please note that we are not a pharmacy or clinic, so we are unable to see patients and do not offer diagnostic and treatment services for individuals.

Vitamin B12 test kit

Fedratinib

Cat. No.: 0225LY-1357
Purity: ≥99%
Identity: Confirmed by NMR.
Size:
Fedratinib
Add to basket

Product Overview

Description: Fedratinib is an ATP-competitive inhibitor primarily targeting JAK2 (IC50: 3 nM), showing significantly higher potency compared to its activity against JAK3.
Synonym: TG-101348; SAR 302503; 936091-26-8; Tg-101348; TG101348; SAR302503; SAR-302503; N-(tert-butyl)-3-((5-methyl-2-((4-(2-(pyrrolidin-1-yl)ethoxy)phenyl)amino)pyrimidin-4-yl)amino)benzenesulfonamide; Fedratinib (SAR302503, TG101348); Inrebic; SAR 302503; N-(1,1-Dimethylethyl)-3-[[5-methyl-2-[[4-[2-(1-pyrrolidinyl)ethoxy]phenyl]amino]-4-pyrimidinyl]amino]benzenesulfonamide; N-tert-butyl-3-[[5-methyl-2-[4-(2-pyrrolidin-1-ylethoxy)anilino]pyrimidin-4-yl]amino]benzenesulfonamide; Benzenesulfonamide, N-(1,1-dimethylethyl)-3-((5-methyl-2-((4-(2-(1-pyrrolidinyl)ethoxy)phenyl)amino)-4-pyrimidinyl)amino)-; N-tert-butyl-3-(5-methyl-2-(4-(2-(pyrrolidin-1-yl)ethoxy)phenylamino)pyrimidin-4-ylamino)benzenesulfonamide; N-Tert-butyl-3-(5-methyl-2-(4-(2-pyrrolidin-1-yl-ethoxy)-phenylamino)-pyrimidin-4-ylamino)-benzenesulfonamide; N-tert-butyl-3-{[5-methyl-2-({4-[2-(pyrrolidin-1-yl)ethoxy]phenyl}amino)pyrimidin-4-yl]amino}benzenesulfonamide
CAS No.: 936091-26-8
Compound CID: 16722836
Formula: C27H36N6O3S
Formula Weight: 524.68

Specification

Targets&IC50: JAK2: 3 nM (cell free); FLT3: 15 nM (cell free); JAK2 (V617F): 3 nM (cell free); RET: 48 nM (cell free)
Relative Density: 1.247 g/cm3
Stability: 3 years in powder form.
Storage: Storage at -20°C.
Applications: Fedratinib can be used in hematology research to investigate the selective inhibition of JAK2 in myeloproliferative neoplasms.

Library Information

Target: JAK; FLT; c-RET
Receptor: FLT3; JAK; JAK2; JAK2 (V617F); RET
Pathways: JAK/STAT signaling; Chromatin/Epigenetic; Stem cell regulation; Apoptosis; Angiogenesis; Tyrosine kinase/adaptors
Plate Number: AOCL-18
Plate Location: d7
Empty Location: a1-h1; a12-h12
Container: 96-well plate
Formulation: 10mM DMSO
DMSO Max Solubility: 240 mg/mL; 457.42 mM
Water Max Solubility: <1 mg/mL (insoluble or slightly soluble)
Ethanol Max Solubility: <1 mg/mL (insoluble or slightly soluble)
ALogP: 5.123
HBA_Count: 5
HBD_Count: 3
Rotatable Bond: 11
Inquiry
0
Inquiry Basket

Copyright © Protheragen. All rights reserves.